← FDA Drug Approvals (Drugs@FDA)

NADOLOL AND BENDROFLUMETHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA · Approved 2008-02-15

Drug application

FDA Application #

ANDA078688

Application type

Abbreviated New Drug Application (Generic)

Brand name

NADOLOL AND BENDROFLUMETHIAZIDE

Generic name

Bendroflumethiazide

Active ingredients

BENDROFLUMETHIAZIDE; NADOLOL

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NATCO PHARMA

First approval

2008-02-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown